A Comparison Of Nebulisation With Dexmedetomidine And Nebulisation With 4% Lignocaine Plus Dexmedetomidine For Awake Fibreoptic Intubatio
Phase 2
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2021/10/037256
- Lead Sponsor
- Indira Gandhi institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patient consent, ASA grade 1 and 2, patient with anticipated difficult intubation(LEMON >2), BMI >30 kg/m2
Exclusion Criteria
patient refusal, airway hypersensitivity, allergy to drugs used (lignocaine/dexmedetomidine),epileptic patients,patients with poor cardiopulmonary reserve, bleeding tendency, obesity, other co-morbid conditions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.sedation/alertness(OAA SCORE) <br/ ><br>2.vocal cord movement(%) <br/ ><br>3.limb movement <br/ ><br>4.fibreoptic intubation score <br/ ><br>5.coughingTimepoint: 0 to 5 min
- Secondary Outcome Measures
Name Time Method 1) To compare the hemodynamic changes of two groups <br/ ><br>2) Dose sparing effect of propofolTimepoint: 0 min,1 min, 2 min , 3 min, 4 min, 5 min